Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2017-11-01
2018-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Virtual Reality and Buzzy Application on Pain Management in Children
NCT05319210
Nonpharmacological Methods for Children in Procedural Pain
NCT04421430
The Effect of Virtual Reality on Pain, Fear and Anxiety by Children During Venipuncture
NCT06727149
Virtual Reality Distraction During Phlebotomy in Children
NCT06336811
Active Virtual Reality Distraction on Procedure-Related Emotional Behaviour, Pain, And Anxiety
NCT07261410
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study is a prospective, randomized and controlled trial. Children aged 7 to 12 years who required phlebotomy were divided into three groups; buzzy, virtual reality, and controls. Data were obtained through face-to-face interviews with the children, their parents, and the observer before and after the procedure. The children's pain levels were assessed and reported by the parents and observers and the children themselves who self-reported using Wong-Baker FACES. The children's anxiety levels were also assessed using the Children's Fear Scale.
The study population consisted of children aged 7 to 12 years who presented to the children's phlebotomy room of the hospital.
Sample of the study consisted of a total of 120 children who met the sample selection criteria and were selected via randomization method.
Children were randomized into three groups: Buzzy (n= 40), VR group (n= 40), and the control group (n= 40).
Data were collected using the Information Form, Wong-Baker FACES Pain Rating Scale, Children's Fear Scale.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Buzzy Group
In this group external cold and vibration-Buzzy was applied to the children during phlebotomy.
Buzzy Group
The Buzzy device was placed 5-10 cm above the injection area and making sure that it was in contact with the skin. The ice pack was kept in the deep freezer and placed into the device before the application. Buzzy was introduced to the children pre-procedure. Cold application and vibration were started pre-procedure and maintained until the procedure was completed. Following the Buzzy application, the device was wiped with 70% alcohol and used for other children. The Buzzy devices were kept in the deep freeze and refrozen. The same person conducted the pain reduction methods during phlebotomy.
Virtual Realitiy-VR Group
In this group Virtual Realitiy-VR was applied to the children during phlebotomy.
Virtual Realitiy-VR Group
VR glasses were introduced to the children pre-procedure. The children were made to watch a video with VR glasses 2-3 minutes before starting the application and it continued until the end of the phlebotomy procedure (three minutes on average). 3D video suggestions (Space Experience, Blue Whale 360 VR Experience) were offered to the children before the phlebotomy procedure and they were asked to choose one of them.
Control Group
In this group, children received routine phlebotomy procedure
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Buzzy Group
The Buzzy device was placed 5-10 cm above the injection area and making sure that it was in contact with the skin. The ice pack was kept in the deep freezer and placed into the device before the application. Buzzy was introduced to the children pre-procedure. Cold application and vibration were started pre-procedure and maintained until the procedure was completed. Following the Buzzy application, the device was wiped with 70% alcohol and used for other children. The Buzzy devices were kept in the deep freeze and refrozen. The same person conducted the pain reduction methods during phlebotomy.
Virtual Realitiy-VR Group
VR glasses were introduced to the children pre-procedure. The children were made to watch a video with VR glasses 2-3 minutes before starting the application and it continued until the end of the phlebotomy procedure (three minutes on average). 3D video suggestions (Space Experience, Blue Whale 360 VR Experience) were offered to the children before the phlebotomy procedure and they were asked to choose one of them.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* were in the age group of 7-12 years,
* Due to undergo phlebotomy for blood testing,
Exclusion Criteria
* had neuro-developmentally delayed,
* had visual, audio, or speech impairments,
* were hospital stay for treatment,
* had a history of sedative, analgesic or narcotic use within 24 hours before admission
7 Years
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bandırma Onyedi Eylül University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Diler Yilmaz
PhD, RN, Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bandirma Onyedi Eylul University
Balıkesir, Bandirma, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BANU-D-YILMAZ-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.